Janusz Krawczyk
University Rd
Gaillimh, C, Ireland
Gaillimh, C, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.
Journal: European journal of haematology
Published: June 30, 2026
Not So Crystal Clear: Pulmonary Crystal-Storing Histiocytosis Without Haematological Disease: A Unique Radiological Manifestation and Review of the Literature.
Journal: Diagnostics (Basel, Switzerland)
Published: June 23, 2026
Generation of induced pluripotent stem cell lines from a patient withKCNQ2-developmental and epileptic encephalopathy pathogenic variant c.783A > C; p.Phe261Leu, and a sibling control.
Journal: Stem cell research
Published: May 01, 2026
Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity.
Journal: International immunopharmacology
Published: November 18, 2025
Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations.
Journal: Stem cells translational medicine
Published: August 26, 2024
Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot.
Journal: Irish journal of medical science
Published: March 22, 2024
A multidisciplinary group-based survivorship intervention for those living with multiple myeloma: a feasibility study.
Journal: Pilot and feasibility studies
Published: September 20, 2023
Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.881C > T; p.Ala294Val (NUIGi059-A, NUIGi059-B, NUIGi059-C) and 3 healthy controls (NUIGi060-A, NUIGi060-B, NUIGi060-C).
Journal: Stem cell research
Published: August 02, 2023
Extreme Symptom Burden for Patients With COVID-19 at the End of Life; Extrapolation of Knowledge Gained to Achieve Sustained Comfort and Dignity for all Patients in Their Last Days of Life1.
Journal: The American journal of hospice & palliative care
Published: March 13, 2023
Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.638C > T; p.Arg213Gln (NUIGi063-A, NUIGi063-B, NUIGi063-C) and 3 healthy controls (NUIGi064-A, NUIGi064-B, NUIGi064-C).
Journal: Stem cell research
Published: January 18, 2023
Reference intervals for clinical biochemistry and haematology tests during normal pregnancy.
Journal: Annals of clinical biochemistry
Published: September 10, 2022
The miR-17-92 cluster: Yin and Yang in human cancers.
Journal: Cancer treatment and research communications
Published: August 15, 2022
Last Updated: 09/26/2026